Chinese Journal of Osteoporosis · Nov 12, 2026

Research progress on mitochondrial dysfunction in chronic obstructive pulmonary disease complicated by sarcopenia

By 田羽佳

Sarcopenia, characterized by persistent reductions in skeletal muscle mass and function, is a common systemic complication of chronic obstructive pulmonary disease (chronic obstructive pulmonary disease,COPD). Skeletal muscle mitochondrial dysfunction is a core pathological mechanism of sarcopenia in COPD, with abnormalities such as reduced mitochondrial biogenesis, abnormal mitochondrial dynamics, impaired autophagy, and oxidative stress closely associated with disruption of the homeostatic balance between skeletal muscle synthesis and breakdown. Exercise training, nutritional supplementation, drugs and active ingredients, and muscle electrical stimulation have been demonstrated to improve sarcopenia in COPD through mechanisms such as increasing skeletal muscle mitochondrial density, alleviating oxidative stress, and regulating imbalances in mitochondrial dynamics. However, drugs targeting mitochondrial dysfunction remain to be developed, and the efficacy and safety of existing traditional Chinese medicine compound formulations and natural active substances still require clinical validation. Future research must further explore therapeutic strategies targeting mitochondrial dysfunction to provide more novel interventions for sarcopenia in COPD.

doi.org/10.3969/j.issn.1006-7108.2026.10.018Interventions

AgingResearch.News